[A 2021 inventory in oncology news].
L’année 2021 dans tous ses états : une synthèse digérée.
Antineoplastic Agents
/ therapeutic use
Brain Neoplasms
/ therapy
Breast Neoplasms
/ therapy
Clinical Trials as Topic
Endometrial Neoplasms
/ therapy
Female
Gastrointestinal Neoplasms
/ therapy
Hematologic Neoplasms
/ therapy
Humans
Immunotherapy
Lung Neoplasms
/ therapy
Male
Medical Oncology
/ trends
Neoplasms
/ therapy
Prostatic Neoplasms
/ therapy
Rhabdomyosarcoma
/ therapy
Urologic Neoplasms
/ therapy
Uterine Cervical Neoplasms
/ therapy
Actualités en cancérologie
New treatments
Nouveaux traitements
Oncology updates
Journal
Bulletin du cancer
ISSN: 1769-6917
Titre abrégé: Bull Cancer
Pays: France
ID NLM: 0072416
Informations de publication
Date de publication:
Jan 2022
Jan 2022
Historique:
received:
20
12
2021
accepted:
21
12
2021
pubmed:
5
1
2022
medline:
29
1
2022
entrez:
4
1
2022
Statut:
ppublish
Résumé
Once again this year, the Editorial Board presents here a summary of the most important advances in treatment and patient care in oncology over the past year. Some of the most important results in breast and gynecological cancers (endometrium and cervix), lung, brain, urologic and digestive cancers. Are also presented progresses in hematological malignancies, pediatric oncology, and of course supportive care essential for our patients.
Identifiants
pubmed: 34980367
pii: S0007-4551(21)00578-6
doi: 10.1016/j.bulcan.2021.12.003
pii:
doi:
Substances chimiques
Antineoplastic Agents
0
Types de publication
Journal Article
Review
Langues
fre
Sous-ensembles de citation
IM
Pagination
8-19Informations de copyright
Copyright © 2021. Published by Elsevier Masson SAS.